News
Comprehensive coverage on the latest pharmaceutical regulatory update and industry activities in China.
Hot topic

POLICY
China Launches the 10th Round of Volume-Based Drug Procurement (VBP)
On November 22, 2024, the China National Joint Drug Procurement Office launched the 10th round of volume-based procurement (VBP), involving 62 drugs. Eligible suppliers must provide basic information by 12:00 PM on December 2 and submit their application dossiers by 10:00 AM on December 12.
Nov 27, 2024

REGULATION
China Standardizes Requirements for Domestic Responsible Persons Designated by Overseas MAHs
On November 14, 2024, China's National Medical Products Administration (NMPA) issued the Interim Provisions on the Management of Designated Domestic Responsible Persons by Overseas Marketing Authorization Holders (MAH) of Drugs.
Nov 19, 2024

REGULATION
Monthly Recap: China Pharmaceutical Regulatory Updates | October 2024
Check out the latest pharma regulatory updates in China: 1. China Releases Several Lists of Reference Listed Drugs (RLDs), 2. China Publishes Re-registration Requirements for Domestically Manufactured Drugs, 3. China Consults on Scope and Procedures for Bioequivalence Test Filings of Chemical Drugs, 4. China CDE Releases Dossier Requirements for the Transfer of Imported Preventive Biological Products to Domestic Production...
Nov 13, 2024

REGULATION
Monthly Recap: China Pharmaceutical Regulatory Updates | September 2024
Check out the latest pharma regulatory updates in China: 1. China CDE Solicits Public Comments on the 86th RLD Lists, 2.China Releases the Fifth List of Pediatric Drugs Encouraged for R&D, 3. China CDE Completes the Consultation on Q&A on Pharmaceutical Similarity Studies of Biosimilars; 4. China CDE Launches Patient-Centered Action for Rare Diseases Encouragement, 5. China NHSA Releases Expert Evaluation Results for Drugs Applied for Inclusion of 2024 NRDL
Oct 12, 2024